Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

forbes.com - Trefis Team - Why Is Merck Stock Still An Undervalued Mega-Cap In Pharma?
Why Is Merck Stock Still An Undervalued Mega-Cap In Pharma?
Forbes

SHENZHEN, CHINA - JULY 27: In this photo illustration, a smartphone displays the logo of Merck & Co., Inc. (NYSE: MRK), a global pharmaceutical company developing medicines and vaccines, in front of a screen showing the company's latest stock…

seekingalpha.com - Richard Durant - Helus Pharma: An Undervalued Psychedelic Platform Approaching A Major Catalyst
Helus Pharma: An Undervalued Psychedelic Platform Approaching A Major Catalyst
Seeking Alpha

Helus Pharma has built a proprietary psychedelic pipeline that currently spans MDD and GAD. The company has two clinical-stage assets and a broader serotonergic discovery platform. Early HLP003 (oral psilocin) and HLP004 (IM DMT) data suggest…

republicworld.com - Melvin Narayan - 2 Killed, 9 Injured in Reactor Blast At Telangana Pharma Unit
2 Killed, 9 Injured in Reactor Blast At Telangana Pharma Unit
Republic World

Pochampally: Two workers were killed and nine others injured after a reactor explosion triggered a fire at a pharmaceutical unit in Telangana's Yadadri Bhuvanagiri district late Friday night, police said. The incident occurred at a pharma company…

bloomberg.com - Sanne Wass - Danish Businesses Most Upbeat in Four Years Despite Pharma Gloom
Danish Businesses Most Upbeat in Four Years Despite Pharma Gloom
Bloomberg

Danish businesses turned the most optimistic in more than four years as stronger confidence in retail and services offset a still-gloomy mood in the industrial sector. The country's business confidence indicator rose to 106.7 in August, Statistics…

seekingalpha.com - Sara Sethiya - Kairos Pharma announces 1-for-7 reverse stock split to maintain NYSE compliance
Kairos Pharma announces 1-for-7 reverse stock split to maintain NYSE compliance
Seeking Alpha

Kairos Pharma () announced on Friday that it will conduct a 1-for-7 reverse stock split effective September 1, 2026, before the market opens. The company's shares will continue trading on the NYSE American under the ticker KAPA. Under the split…

fool.com - Seena Hassouna - Pharma ETF or Biotech ETF: Which Matches Your Investing Mindset?
Pharma ETF or Biotech ETF: Which Matches Your Investing Mindset?
The Motley Fool

The iShares U.S. Pharmaceuticals ETF (IHE +1.01%) offers a lower-cost entry into diversified pharmaceutical leaders, while the Invesco Biotechnology & Genome ETF (PBE +1.07%) targets high-growth biotech and genetic engineering firms. Both funds…

fool.com - Motley Fool Transcribing - Lantern Pharma (LTRN) Q2 2026 Earnings Call Transcript
Lantern Pharma (LTRN) Q2 2026 Earnings Call Transcript
The Motley Fool

Friday, Aug. 14, 2026 at 9:00 a.m. ET President and Chief Executive Officer - Panna Sharma Chief Financial Officer - David R. Margrave Cash, Cash Equivalents, and Marketable Securities -- $7.4 million at June 30, 2026, reflecting the receipt of…

law360.com - Gianna Ferrarin - Pharma Co. Loses Challenge To $3M Acne Drug Arb. Award
Pharma Co. Loses Challenge To $3M Acne Drug Arb. Award
Law360

A New York federal court confirmed an arbitrator's finding that Sun Pharmaceuticals breached an agreement with the owner of an acne drug by seeking regulatory approval to market a version of... To view the full article, register now. Already a…

thehindubusinessline.com - Poor-quality medical devices being sold in India, stronger finished-product testing needed, says Pharma Secretary
Poor-quality medical devices being sold in India, stronger finished-product testing needed, says Pharma Secretary
BusinessLine

Too may poor quality medical device products are being made and sold in India and the regulatory system is not able to control all of them, said Department of Pharmaceuticals Secretary Manoj Joshi, calling for stronger testing of finished devices…

marketbeat.com - Ascentage Pharma Group International (NASDAQ:AAPG) Trading Down 4.9% - Time to Sell?
Ascentage Pharma Group International (NASDAQ:AAPG) Trading Down 4.9% - Time to Sell?
MarketBeat

Shares of Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report) were down 4.9% during trading on Friday. The stock traded as low as $17.15 and last traded at $17.15. 307 shares were traded during mid-day trading, a…

marketbeat.com - Ascentage Pharma Group International's (AAPG) Buy Rating Reaffirmed at BTIG Research
Ascentage Pharma Group International's (AAPG) Buy Rating Reaffirmed at BTIG Research
MarketBeat

Ascentage Pharma Group International (NASDAQ:AAPG - Get Free Report)'s stock had its 'buy' rating restated by stock analysts at BTIG Research in a research note issued to investors on Friday, Benzinga reports. They presently have a $48.00 price…

bloomberg.com - Bob Van Voris - Joss Sackler Gets House Arrest in Case Tied to Opioid Addiction
Joss Sackler Gets House Arrest in Case Tied to Opioid Addiction
Bloomberg

The wife of former Purdue Pharma LP board member David Sackler was sentenced to home confinement for destroying WhatsApp messages with a Colombian pharmacist who was supplying her with illegal opioids to feed her addiction to painkillers. Joss…

dynamitenews.com - Ayushi Bisht - Stock Market Today: Sensex Gains 163 Points, Nifty Near 24,300; Eternal Top Gainer | Dynamite News
Stock Market Today: Sensex Gains 163 Points, Nifty Near 24,300; Eternal Top Gainer | Dynamite News
News: Today's News Headlines & Daily Updates from Sports, Movies, Politics, Business | Dynamite News

Post Published By: Ayushi Bisht Updated: 21 August 2026, 12:05 PM IST New Delhi: Indian equity markets opened higher on Friday, extending the previous session's gains despite mixed global signals and rising concerns over crude oil prices and US…

cyclingnews.com - Jackie Tyson - Vuelta a España stage 1 time trial start times
Vuelta a España stage 1 time trial start times
Cyclingnews

This year's Vuelta a España will be shaped across Monaco, France and Andorra in the opening days and position the GC for the final two weeks of climbing and hot weather in southern Spain. There is instant intrigue for the first leader's red…

techcrunch.com - Connie Loizos - Michael Polansky is training an AI model on skin that's still alive
Michael Polansky is training an AI model on skin that's still alive
TechCrunch

Michael Polansky is remarkably unassuming for someone operating in a corner of the world known for outsize egos. Seated at a leafy patio outside a popular bakery in Mill Valley, an affluent town about 15 miles north of San Francisco, Polansky…

Receive a Daily briefing on Pharma Industry News

Get Started